Expert Advice 24 May 2024 Mission statement, the key to success for biotech companies Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture. May 24, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 24 May 2024How biotech is tackling myasthenia gravis To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion. May 24, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 23 May 2024 Is prime editing ready for prime time? Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology. May 23, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 May 2024 10 notable pharma and biotech venture capital arms Discover 10 big pharma and biotech companies that have spun out their own venture capital arms to invest in startups in the industry. May 23, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 May 2024 The undruggable cancer target: KRAS inhibitors move ahead in the clinic Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout. May 22, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about. May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Inside Labiotech 20 May 2024 Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card! We would like to learn more about you. Participate in the 2024 Labiotech Reader Survey for a chance to win a €250 or $250 Amazon gift card! May 20, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Expert Advice 17 May 2024 How to use LinkedIn to ace your biotech job search and advance your career LinkedIn is the most powerful tool to develop your career in the biotech industry. Delve into the strategies to use it efficiently. May 17, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 17 May 2024Isarna Therapeutics revolutionizes ophthalmology with antisense oligonucleotides German-headquartered Isarna Therapeutics is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology – transforming growth factor beta (TGF-B) signaling. Precise modulation of TGF-B pathways using antisense therapy may result in safer and more effective treatment options for a broad range of indications. Isarna Therapeutics’s lead compound, ISTH0036, is in […] May 17, 2024 Share WhatsApp Twitter Linkedin Email
Expert Advice 16 May 2024 Types of clinical trial designs: The essentials The average journey of a drug from trial to market is 10.5 years. Delve into the different clinical trials designs and their specificities. May 16, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2024 Five orthobiologics companies leading the way in the field Discover five of the top orthobiologics companies leading the way in the field, as the market is set to grow in the next few years. May 16, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2024 Drugs for IgA nephropathy on the rise in the clinic As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better. May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email